Publisher's Synopsis
Presents an overview of the standard operating procedures of the German Phase I,II and III Study Groups, the New Drug Development Group, and the Study Group of Pharmacology in Oncology and Haematology. The text includes business meetings since 1986 as well as accounts of the studies performed.